首页> 外文期刊>Biochimica et biophysica acta. Molecular basis of disease: BBA >Two new mutations in the human E1β subunit of branched chain α-ketoacid dehydrogenase associated with maple syrup urine disease
【24h】

Two new mutations in the human E1β subunit of branched chain α-ketoacid dehydrogenase associated with maple syrup urine disease

机译:枫糖浆尿病相关人支链α-酮酸脱氢酶E1β亚基的两个新突变

获取原文
获取原文并翻译 | 示例
           

摘要

Maple syrup urine disease (MSUD) is an autosomal recessive disorder caused by defective function of the mitochondrial branched chain α-ketoacid dehydrogenase (BCKD) complex. Mutations in both alleles of any of three genes for component proteins result in the clinical phenotype. Two discrete mutant alleles for the E1β subunit of the decarboxylase component in a proband with MSUD are defined and parental origin of each allele identified. The maternal mutation, an A to T transversion at nucleotide 526 in the coding sequence, potentiates an asparagine to tyrosine change at position 126 (N126Y). The paternal mutant allele contains a C to T transition at nucleotide 970 introducing a stop codon (R274*). Western blot analysis revealed a 75% reduction in the E1β-N126Y protein and an absence of the R274* truncated protein in proband cells. Both mutant proteins could be synthesized, imported into mitochondria, and processed in vitro. Functional analysis of the mutant proteins provided new information on the role of E1β in the activity of BCKD. In vivo the E1β-N126Y protein associated into macromolecular complexes indistinguishable from those formed with the wild type E1β protein. However, catalytic activity of these complexes in proband cells was <1% of wild type activity. Alignment comparisons with other thiamin pyrophosphate-requiring enzymes suggests the N126Y substitution could interfere with interactions of the protein with the cofactor causing inactivity. The truncated E1β-R274* protein is unstable and not found in mitochondria from the patient derived cells.
机译:枫糖浆尿病(MSUD)是由线粒体支链α-酮酸脱氢酶(BCKD)复合体功能缺陷引起的常染色体隐性遗传疾病。组成蛋白的三个基因中任何一个的两个等位基因突变都会导致临床表型。定义了具有MSUD的先证者中脱羧酶组分E1β亚基的两个离散突变等位基因,并鉴定了每个等位基因的亲本来源。母体突变是编码序列中核苷酸526的A到T转换,可增强天冬酰胺在位置126(N126Y)上的酪氨酸变化。父系突变体等位基因在核苷酸970处具有C到T的过渡,引入了终止密码子(R274 *)。蛋白质印迹分析显示,先证者细胞中E1β-N126Y蛋白降低了75%,而R274 *截短蛋白不存在。两种突变蛋白都可以合成,导入线粒体并进行体外加工。突变蛋白的功能分析提供了有关E1β在BCKD活性中的作用的新信息。在体内,与大分子复合物相关的E1β-N126Y蛋白与野生型E1β蛋白形成的蛋白没有区别。但是,这些复合物在先证者细胞中的催化活性小于野生型活性的1%。与其他需要硫胺素焦磷酸盐的酶的比对比较表明,N126Y取代可能会干扰蛋白质与辅因子的相互作用,从而导致无活性。截短的E1β-R274*蛋白不稳定,在患者来源的细胞的线粒体中未发现。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号